热门出版物 - 学术资源搜索

h5 指数:47
h5 中位数:65

h5 指数是指在过去整整 5 年中所发表文章的 h 指数。h 指在 2018-2022 年间发表的 h 篇文章每篇至少都被引用过 h 次的最大值。隐藏

出版物的 h5 中位数，是指出版物的 h5 指数所涵盖的所有文章获得的引用次数的中位值。隐藏

#10 Medicinal Chemistry

标题/作者	引用次数	年份
Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers J Popovici-Muller, RM Lemieux, E Artin, JO Saunders, FG Salituro, ... ACS Medicinal Chemistry Letters 9 (4), 300-305	320	2018
Marine Natural Products in Medicinal Chemistry C Jiménez ACS Medicinal Chemistry Letters 9 (10), 959-961	217	2018
Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2 MM Ghahremanpour, J Tirado-Rives, M Deshmukh, JA Ippolito, ... ACS Medicinal Chemistry Letters 11 (12), 2526-2533	168	2020
PROTAC Technology: Opportunities and Challenges H Gao, X Sun, Y Rao ACS Medicinal Chemistry Letters 11 (3), 237-240	154	2020
Advantages of the Parent Nucleoside GS-441524 over Remdesivir for Covid-19 Treatment VC Yan, FL Muller ACS Medicinal Chemistry Letters 11 (7), 1361-1366	138	2020
LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor Activity ZQ Bonday, GS Cortez, MJ Grogan, S Antonysamy, K Weichert, ... ACS Medicinal Chemistry Letters 9 (7), 612-617	132	2018
Expanding the Medicinal Chemist Toolbox: Comparing Seven C (sp2)–C (sp3) Cross-Coupling Methods by Library Synthesis AW Dombrowski, NJ Gesmundo, AL Aguirre, KA Sarris, JM Young, ... ACS Medicinal Chemistry Letters 11 (4), 597-604	98	2020
Synthesis and Biological Screening of Pyrano [3, 2-c] quinoline Analogues as Anti-inflammatory and Anticancer Agents KD Upadhyay, NM Dodia, RC Khunt, RS Chaniara, AK Shah ACS Medicinal Chemistry Letters 9 (3), 283-288	95	2018
Vorasidenib (AG-881): A First-in-Class, Brain-Penetrant Dual Inhibitor of Mutant IDH1 and 2 for Treatment of Glioma Z Konteatis, E Artin, B Nicolay, K Straley, AK Padyana, L Jin, Y Chen, ... ACS Medicinal Chemistry Letters 11 (2), 101-107	95	2020
Chemical Strategies for Half-Life Extension of Biopharmaceuticals: Lipidation and Its Alternatives EM Bech, SL Pedersen, KJ Jensen ACS Medicinal Chemistry Letters 9 (7), 577-580	89	2018
Harnessing Polypharmacology with Medicinal Chemistry ML Bolognesi ACS Medicinal Chemistry Letters 10 (3), 273-275	89	2019
Carbon Dots from Sugars and Ascorbic Acid: Role of the Precursors on Morphology, Properties, Toxicity, and Drug Uptake S Cailotto, E Amadio, M Facchin, M Selva, E Pontoglio, F Rizzolio, ... ACS Medicinal Chemistry Letters 9 (8), 832-837	88	2018
Emerging Utility of Fluorosulfate Chemical Probes LH Jones ACS Medicinal Chemistry Letters 9 (7), 584-586	87	2018
Targeting IRAK4 for Degradation with PROTACs J Nunes, GA McGonagle, J Eden, G Kiritharan, M Touzet, X Lewell, ... ACS Medicinal Chemistry Letters 10 (7), 1081-1085	83	2019
Transforming Computational Drug Discovery with Machine Learning and AI JS Smith, AE Roitberg, O Isayev ACS Medicinal Chemistry Letters 9 (11), 1065-1069	81	2018
Development of Highly Potent and Selective Steroidal Inhibitors and Degraders of CDK8 JM Hatcher, ES Wang, L Johannessen, N Kwiatkowski, T Sim, NS Gray ACS Medicinal Chemistry Letters 9 (6), 540-545	78	2018
Solution Conformations Shed Light on PROTAC Cell Permeability Y Atilaw, V Poongavanam, C Svensson Nilsson, D Nguyen, A Giese, ... ACS Medicinal Chemistry Letters 12 (1), 107-114	76	2020
Discovery of a Novel cGAMP Competitive Ligand of the Inactive Form of STING T Siu, MD Altman, GA Baltus, M Childers, JM Ellis, H Gunaydin, H Hatch, ... ACS Medicinal Chemistry Letters 10 (1), 92-97	72	2018
Dual GSK-3β/AChE Inhibitors as a New Strategy for Multitargeting Anti-Alzheimer’s Disease Drug Discovery XY Jiang, TK Chen, JT Zhou, SY He, HY Yang, Y Chen, W Qu, F Feng, ... ACS Medicinal Chemistry Letters 9 (3), 171-176	71	2018
The Advent of Generative Chemistry Q Vanhaelen, YC Lin, A Zhavoronkov ACS Medicinal Chemistry Letters 11 (8), 1496-1505	70	2020

1 - 20

计算机程序会自动估算并确定日期和引用次数。